The decision follows recent calls from AI lab leaders, including OpenAI's and Anthropic's, to slow the pace of frontier model development.

The deal marks one of the chipmaker's largest AI bets and adds a prominent researcher to its leadership.

The repurchase program runs through January 2028 and the company framed it as confidence in its long-term opportunity.

The filing offers the first detailed look at the AI developer's costs and ambitions as it moves toward a listing.

The move deepened supply uncertainty and pushed crude higher, adding to global inflation concerns.

Rising bond yields, higher crude prices and AI jitters combined to pressure equities, with the Dow closing down 0.67%.

The delay adds to Boeing's certification backlog and weighed on the Dow.

Desai will report to Mark Zuckerberg as Meta builds out an enterprise AI business.

The financing push comes as a judge weighs a settlement in the related litigation.

A new notice targets investment structures used to reduce tax bills, drawing attention from major banks.

The report raises questions about data controls at the central bank.

The milestone flight deployed Starlink satellites and advances the rocket's reusability program.

The investment expands Samsung's push into global AI data-center infrastructure.

The investment deepens a partnership in lung cancer drug development.

A US jury found infringement tied to iPhone and Apple Watch haptic technology.

The tie-up lets merchants accept stablecoins and broadens Citi's crypto footprint.

The deal adds a targeted cancer asset from China to Merck's oncology pipeline.

The approval validates AbbVie's $8.7 billion Cerevel acquisition.